Therefore, to determine whether Wnt/β-catenin signaling is implicated in hepatocarcinogenesis, we examined the expression of Wnt/β-catenin signaling components, including Wnt1, LEF, and TCF4, in tissue samples from liver cancer patients. The gene discussed is WNT1; the disease is liver cancer.